详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Substantial Improvement of Stroke Care in China

文献详情

资源类型：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China [2]China National Clinical Research Center for Neurological Diseases, Ministry of Science and Technology, Beijing [3]Illinois Neurological Institute Stroke Network, Sisters of the Third Order of St Francis Healthcare System, University of Illinois College of Medicine, Peoria

出处：

DOI：

ISSN：

关键词： epidemiology rehabilitation research stroke thrombolytic therapy

摘要：

[No abstract available]

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2017]版：

大类 | 2 区

医学

小类 | 2 区临床神经病学 2 区外周血管病

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区临床神经病学 1 区外周血管病

JCR分区：

出版当年[2016]版：

Q1 PERIPHERAL VASCULAR DISEASE Q1 CLINICAL NEUROLOGY

最新[2023]版：

Q1 CLINICAL NEUROLOGY Q1 PERIPHERAL VASCULAR DISEASE

影响因子： 7.9 最新[2023版] 8.2 最新五年平均 6.032 出版当年[2016版] 6.494 出版当年五年平均 5.787 出版前一年[2015版] 6.239 出版后一年[2017版]

第一作者：

第一作者机构： [1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China [2]China National Clinical Research Center for Neurological Diseases, Ministry of Science and Technology, Beijing

共同第一作者：

通讯作者：

通讯机构： [1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China [2]China National Clinical Research Center for Neurological Diseases, Ministry of Science and Technology, Beijing [*1]Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, 6 Tiantan Xili, Dongcheng District, Beijing 100050, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]2018年中国卒中管理及研究进展 [2]Advances in stroke care and research in 2010 [3]Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses [4]Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China Analysis of the Results From the Chinese National Stroke Registry (CNSR) [5]Totaled Health Risks in Vascular Events Score Predicts Clinical Outcome and Symptomatic Intracranial Hemorrhage in Chinese Patients After Thrombolysis [6]Renal Dysfunction and In-Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy [7]VALIDATION OF THE SIMPLIFIED STROKE-THROMBOLYTIC PREDICTIVE INSTRUMENT AMONG CHINESE PATIENTS WITH REPERFUSION THERAPY [8]Rt-PA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke [9]Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke [10]r-tPA Thrombolytic Therapy in Combination With Remote Ischemic Conditioning for Acute Ischemic Stroke Recovery (rtPA-RIC)